NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/23/2026
Back to search
Official data from USPTO
METIRRA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
06/23/2026
Trademark type
Word
Nice classes
5, 44
Filing date
07/09/2025
Registration date
06/23/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/23/2026
Last transaction
06/23/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
TENG, SIMON
Law office
L50
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Metirra Pty Ltd
Envision Sciences Pty Ltd
Representatives
Carrie Hedayati LOCH APC
Technical classification
Nice Classes
Class 5Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the prevention and treatment of cancer; medical preparations for the treatment of cancer; pharmaceutical and veterinary preparations and substances for the treatment of cancerous tumors; medical biological preparations and substances for the prevention and treatment of infectious diseases; diagnostic biomarker reagents for medical purposes; diagnostic biomarkers for in vitro testing for medical use; diagnostic biomarkers for use in assessment of genomic analysis for medical use; diagnostic biomarkers for use in assessment of chemical skin sensitizers for medical use; diagnostic biomarkers for use in assessment of toxicological property of chemical compounds and mixtures for medical use; biopharmaceuticals for the treatment of cancer; biotechnological preparations for medical purposes and medical usebiological reagents for medical purposes; biocides; diagnostic biomarkers for use in assessment of chemical respiratory sensitizers for medical use; diagnostic reagents and assays for detecting antigens for medical purposes; biotherapeuticstherapeutic pharmaceutical for the treatment of cancer; pharmaceutical biosimilars for human use for the treatment of cancer; medical preparationsimmunotherapeutic agents for the treatment and prevention of cancers and tumors; diagnostic biomarkers and medical antibodies for use in medical imaging
Class 44
Disease diagnosis services being performing diagnosis of diseases; medical analysis for the diagnosis and treatment of persons; medical analysis services for the diagnosis and treatment of persons; medical analysis services for cancer diagnosis and prognosis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical services; medical servicesconsulting services in the field of healthcare; medical consultancy services; provision of information in the field of cancer preventionscreeningdiagnosistreatment; RNA or DNA analysis for cancer diagnosis and prognosis; medical pathology services; medical services in the field of oncology; providing medical information to patients and medical professionals in the form of medical reports in the field of cancer preventionscreeningdiagnosistreatment; medical information; consulting services in the field of medical care
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/23/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/05/2026
PUBO
PUBLISHED FOR OPPOSITION
05/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/29/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/06/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/01/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/01/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/01/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/13/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/13/2026
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/13/2026
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/13/2026
RFNT
REFUSAL PROCESSED BY IB
03/12/2026
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/26/2026
RFRR
REFUSAL PROCESSED BY MPU
02/26/2026
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/30/2026
CNRT
NON-FINAL ACTION WRITTEN
01/29/2026
DOCK
ASSIGNED TO EXAMINER
01/29/2026
MAFR
APPLICATION FILING RECEIPT MAILED
01/28/2026
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/28/2026
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
01/22/2026
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
09/26/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/18/2025
Continuous trademark protection
Get notified about every new filing that threatens METIRRA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.